Oramed Pharma (ORMP) Announces Completion of Phase IIb Oral Insulin Study
Tweet Send to a Friend
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced today that all follow-up visits in the Company's Phase IIb study of its oral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
